BioLineRx Ltd.
BLRXNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $9.17M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.95$3.95
- Volume (live)
- -
- Avg. volume (3M)
- 15.35K
BioLineRx (BLRX) Stock Price & Financial Analysis
BioLineRx Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.99 - $2.17 |
|---|---|
| 52-Week High | $3.95 |
| 52-Week Low | $1.95 |
| Open | $2.07 |
| Volume (last close) | 5.20K |
| Average Volume (3M) | 15.35K |
| Revenue (TTM) | 1.39M |
|---|---|
| Net Income (TTM) | -7.97M |
| Free Cash Flow (TTM) | -10.84M |
| EPS (TTM) | −$1.86 |
| Profit Margin | -572.48% |
| Operating Margin | -874.28% |
| Return on Equity (ROE) | -57.87% |
| Debt to Equity | 0.49 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 9.17M |
|---|---|
| Shares Outstanding | 4.44M |
| Price to Sales (P/S) | 6.59 |
| Price to Book (P/B) | 0.67 |
| EV/EBITDA | -1.37 |
| 50-Day MA | $2.51 |
|---|---|
| 200-Day MA | $2.77 |
| 1-Year Change | −43.61% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
BioLineRx at a Glance
As of the Oct 22, 2026 close, BioLineRx (BLRX) has a market capitalization of $9.17M. The stock trades at 6.6× sales. Over the trailing twelve months it lost $7.97M on revenue of $1.39M and burned $10.84M of free cash flow. Revenue fell 94.2% year over year.
As of its latest reported balance sheet, it holds $4.63M in cash and securities against $6.70M of debt, a net debt position of $2.07M.
BioLineRx does not currently pay a dividend.
The share price is down 43.6% over the past year. At $2.06 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $1.95 to $3.95, below its 200-day moving average of $2.77.
Frequently Asked Questions About BioLineRx
What is the current stock price for BLRX?
As of the Oct 22, 2026 close, BLRX stock trades at $2.06. The 52-week range is $1.95–$3.95, with a day range of $1.99–$2.17.
What is the P/E ratio for BLRX?
The P/E ratio (Price-to-Earnings) for BLRX is shown in the Key Statistics section. This valuation metric helps compare BioLineRx Ltd. to industry peers.
Does BLRX pay dividends?
BioLineRx does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for BLRX?
Analyst ratings and recommendations for BLRX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of BLRX?
As of the Oct 22, 2026 close, BioLineRx's market capitalization is $9.2M, classifying it as a micro-cap company. BioLineRx operates in the Healthcare sector within the Biotechnology industry.